dc.contributor.author | Wu, Xinggang![]() |
|
dc.contributor.author | Park, Mikyung![]() |
|
dc.contributor.author | Sarbassova, Dilara A.![]() |
|
dc.contributor.author | Ying, Haoqiang![]() |
|
dc.contributor.author | Lee, Min Gyu![]() |
|
dc.contributor.author | Bhattacharya, Rajat![]() |
|
dc.contributor.author | Ellis, Lee![]() |
|
dc.contributor.author | Peterson, Christine B.![]() |
|
dc.contributor.author | Hung, Mien-Chie![]() |
|
dc.contributor.author | Lin, Hui-Kuan![]() |
|
dc.contributor.author | Bersimbaev, Rakhmetkazhi I.![]() |
|
dc.contributor.author | Song, Min Sup![]() |
|
dc.contributor.author | Sarbassov, Dos D.![]() |
|
dc.date.accessioned | 2022-02-02T15:19:56Z | |
dc.date.available | 2022-02-02T15:19:56Z | |
dc.date.issued | 2019-08-31 | |
dc.identifier.citation | Wu, X., Park, M., Sarbassova, D. A., Ying, H., Lee, M. G., Bhattacharya, R., Ellis, L., Peterson, C. B., Hung, M., Lin, H., Bersimbaev, R. I., Song, M. S., & Sarbassov, D. D. (2020). A chirality‐dependent action of vitamin C in suppressing Kirsten rat sarcoma mutant tumor growth by the oxidative combination: Rationale for cancer therapeutics. International Journal of Cancer, 146(10), 2822–2828. https://doi.org/10.1002/ijc.32658 | en_US |
dc.identifier.uri | http://nur.nu.edu.kz/handle/123456789/6016 | |
dc.description.abstract | Kirsten rat sarcoma (KRAS) mutant cancers, which constitute the vast majority of pancreatic tumors, are characterized by their resistance to established therapies and high mortality rates. Here, we developed a novel and extremely effective combinational therapeutic approach to target KRAS mutant tumors through the generation of a cytotoxic oxidative stress. At high concentrations, vitamin C (VC) is known to provoke oxidative stress and selectively kill KRAS mutant cancer cells, although its effects are limited when it is given as monotherapy. We found that the combination of VC and the oxidizing drug arsenic trioxide (ATO) is an effective therapeutic treatment modality. Remarkably, its efficiency is dependent on chirality of VC as its enantiomer D-optical isomer of VC (D-VC) is significantly more potent than the natural L-optical isomer of VC. Thus, our results demonstrate that the oxidizing combination of ATO and D-VC is a promising approach for the treatment of KRAS mutant human cancers | en_US |
dc.language.iso | en | en_US |
dc.publisher | International Journal of Cancer | en_US |
dc.rights | Attribution-NonCommercial-ShareAlike 3.0 United States | * |
dc.rights.uri | http://creativecommons.org/licenses/by-nc-sa/3.0/us/ | * |
dc.subject | Type of access: Open Access | en_US |
dc.subject | Kirsten rat sarcoma | en_US |
dc.title | A CHIRALITY-DEPENDENT ACTION OF VITAMIN C IN SUPPRESSINGKIRSTEN RAT SARCOMA MUTANT TUMOR GROWTH BY THE OXIDATIVECOMBINATION: RATIONALE FOR CANCER THERAPEUTICS | en_US |
dc.type | Article | en_US |
workflow.import.source | science |
The following license files are associated with this item: